BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2652614)

  • 21. Monotherapy with cyclosporine in kidney transplantation.
    Andreu J; Campistol JM; Oppenheimer F; Ricart MJ; Vilardell J; Carretero P
    Transplant Proc; 1990 Oct; 22(5):2270-1. PubMed ID: 2219364
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclosporin A as sole immunosuppressive agent for renal transplantation in children: effect on catch-up growth.
    Hodson EM; Knight JF; Sheil AG; Roy LP
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1687-92. PubMed ID: 2652553
    [No Abstract]   [Full Text] [Related]  

  • 23. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
    Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 25. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract]   [Full Text] [Related]  

  • 26. Renal allograft biopsy and conversion of cyclosporine to azathioprine.
    Shen SY; Weir MR; Coughlin TR
    Transplantation; 1989 Feb; 47(2):223-9. PubMed ID: 2645702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporin A (CsA) and azathioprine (Aza) overlap in renal allografts with impaired renal function.
    Castelao AM; Griñó JM; Sabaté I; Gilvernet S; Andres E; Sabater R; Alsina J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1540-1. PubMed ID: 2652497
    [No Abstract]   [Full Text] [Related]  

  • 28. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation.
    Nestor ZJ; Rocher LL; Merion RM; Swartz RD; Turcotte JG; Campbell DA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal transplantation in older patients on peritoneal dialysis.
    Cardella CJ; Harding ME; Abraham G; Robinson C; Oreopoulos D; Uldall PR; Jordan M; Cook G; Struthers N; Honey R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2022-3. PubMed ID: 2652660
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of three immunosuppressive protocols in patients aged over 50 years.
    Fryd DS; So SK; Kruse L; Canafax DM; Sutherland DE; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1530-1. PubMed ID: 3274374
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal transplants monitored with percutaneous biopsy and fine-needle aspiration cytology.
    Lloveras J; Cuxart M; Munné A; Orfila A; Mato E; Masramon J; Serrano S
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):101-2. PubMed ID: 3051577
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM; Sterioff S; Bias W
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine.
    Schulak JA; Moritz CE; Hricik DE
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1709-11. PubMed ID: 2652560
    [No Abstract]   [Full Text] [Related]  

  • 34. Pretreatment of human renal allografts with monoclonal antibodies to induce long-term tolerance.
    Taube D; Welsh KI; Bewick M; Dische FE; Palmer A; Parsons V; Snowden S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1961-3. PubMed ID: 3274456
    [No Abstract]   [Full Text] [Related]  

  • 35. Conversion from cyclosporine to azathioprine improves renal function without increased risk of graft failure.
    Maddux MS; Veremis SA; Pollak R; Mozes MF
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2007-9. PubMed ID: 3079066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
    Hourmant M; Buzelin F; Dubigeon P; Soulillou JP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073
    [No Abstract]   [Full Text] [Related]  

  • 37. Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution.
    Gruber SA; Chavers B; Payne WD; Fryd DS; Canafax DM; Simmons RL; Najarian JS; Matas A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2139-40. PubMed ID: 2652690
    [No Abstract]   [Full Text] [Related]  

  • 38. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
    [No Abstract]   [Full Text] [Related]  

  • 39. The course of chronic, progressive renal allograft dysfunction during cyclosporine therapy is modified by addition of azathioprine.
    Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Turcotte JG; Campbell DA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1529-31. PubMed ID: 2652493
    [No Abstract]   [Full Text] [Related]  

  • 40. The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection.
    Kountz SL; Rao TK; Butt KH
    Transplant Proc; 1975 Mar; 7(1):73-7. PubMed ID: 1091048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.